Current status and future prospects of point-of-care testing around the globe

Expert Review of Molecular Diagnostics

Volumn 15, Issue 7, 2015, Pages 853-855

  Abel, Gyorgy ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

high throughput; immunohematology; microbiology; molecular diagnostic; point of care

Indexed keywords

HEMOGLOBIN A1C;

AUTOMATION; BLOOD EXAMINATION; CLINICAL CHEMISTRY; COST BENEFIT ANALYSIS; HIV TEST; HOSPITAL LABORATORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCHEMISTRY; LABORATORY TEST; MICROBIOLOGY; MOLECULAR DIAGNOSIS; POINT OF CARE TESTING; REVIEW; ECONOMICS; HEALTH; POINT OF CARE SYSTEM; STANDARDS; TRENDS;

GLOBAL HEALTH; HUMANS; POINT-OF-CARE SYSTEMS; POINT-OF-CARE TESTING;

EID: 84933530147     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2015.1060126     Document Type: Review

References (20)

1. McPartlin DA, O'Kennedy RJ. Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations. Expert Rev Mol Diagn 2014;14(8):979-98
2. Nichols JH. Quality in point-of-care testing. Expert Rev Mol Diagn 2003;3(5):563-72
3. Schimke I. Quality and timeliness in medical laboratory testing. Anal Bioanal Chem 2009;393(5):1499-504
4. Nichols JH, Christenson RH, Clarke W, et al. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: Evidence-based practice for point-of-care testing. Clin Chim Acta 2007;379(1-2):14-28
5. Point of Care Diagnostics. BCC Healthcare Research Report 2015
6. Malone B. Spotlight on point-of-care testing. AACC Clinical Laboratory News. October 2012
7. U.S. clinical laboratory and pathology testing 2013-2015: Market analysis, trends, and forecasts. G2 Intelligence 2013
8. Hospital-Based Point-of-Care Diagnostics: Products, Players, and Outlook to 2017. Espicom Business Intelligence 2012
9. Gubbins PO, Klepser ME, Dering-Anderson AM, et al. Point-of-care testing for infectious diseases: Opportunities, barriers, and considerations in community pharmacy. J Am Pharm Assoc 2014;54(2):163-71
10. Guideline regarding clinical laboratories. Ministry of Health, Labour and Welfare; Tokyo, Japan: 2015
11. Tirimacco R. Evolution of point-of-care testing in Australia. Review. Clin. Biochem Rev 2010;31(8):75-80
12. Sunder T. Point of care healthcare technology in India - Challenges and journey ahead: A clinician's perspective. IEEE Life Sci 2013
13. Mace CR, Ryan US. A unique approach to business strategy as a means to enable change in global healthcare: a case study. Clin Chem 2012;58(9):1302-5
14. Choudhary T, Rajamanickam GP, Dendukuri D. Woven electrochemical fabric-based test sensors (WEFTS): a new class of multiplexed electrochemical sensors. Lab Chip 2015;15(9):2064-72
15. Stevens W, Natasha Gous N, Ford N, Scott LE. Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions. BMC Med 2014;12:173-9
16. Scott L. A laboratorian's experience of implementing multiple point-of-care testing in HIV antiretroviral treatment clinics in South Africa. S Afr Med J 2013;103(12):883-4
17. Hyle EP, Jani IV, Lehe J, et al. The clinical and economic impact of point-of-care CD4 testing in Mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med 2014;11(9):1-15
18. Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis 2013;26(1):73-9
19. Zumla A, Al-Tawfiq JA, Enne VI, et al. Emerging respiratory tract infections 4. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections - needs, advances, and future prospects. Lancet Infect Dis 2014;14:1123-34
20. Price CP, Kricka LJ. Improving healthcare accessibility through point-of-care technologies. Clin Chem 2007;53(9):1665-75